These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone. Awasthi S; Lubinski JM; Shaw CE; Barrett SM; Cai M; Wang F; Betts M; Kingsley S; Distefano DJ; Balliet JW; Flynn JA; Casimiro DR; Bryan JT; Friedman HM J Virol; 2011 Oct; 85(20):10472-86. PubMed ID: 21813597 [TBL] [Abstract][Full Text] [Related]
13. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. Hoshino Y; Pesnicak L; Dowdell KC; Burbelo PD; Knipe DM; Straus SE; Cohen JI J Infect Dis; 2009 Oct; 200(7):1088-95. PubMed ID: 19702506 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine. Hook LM; Awasthi S; Cairns TM; Alameh MG; Fowler BT; Egan KP; Sung MMH; Weissman D; Cohen GH; Friedman HM Viruses; 2022 Mar; 14(3):. PubMed ID: 35336946 [TBL] [Abstract][Full Text] [Related]
15. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes. Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955 [TBL] [Abstract][Full Text] [Related]
16. The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs. Bernstein DI; Farley N; Bravo FJ; Earwood J; McNeal M; Fairman J; Cardin R Vaccine; 2010 May; 28(21):3748-53. PubMed ID: 19857450 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4 Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L J Virol; 2019 May; 93(9):. PubMed ID: 30787156 [TBL] [Abstract][Full Text] [Related]
18. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs. Fotouhi F; Soleimanjahi H; Roostaee MH; Dalimi Asl A Iran Biomed J; 2008 Apr; 12(2):59-66. PubMed ID: 18506211 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs. Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834 [TBL] [Abstract][Full Text] [Related]
20. Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig. Bernstein DI; Earwood JD; Bravo FJ; Cohen GH; Eisenberg RJ; Clark JR; Fairman J; Cardin RD Vaccine; 2011 Mar; 29(11):2071-8. PubMed ID: 21238569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]